-transparent.png){kind=logo}
Two cell lines have been isolated from separate samples, taken at the same time, from the peripheral blood of a case of myelomonocytic leukaemia. One of these (CESS-B) is a typical B cell line obtained after treatment of the peripheral blood white cells with Epstein-Barr virus (EBV). The second line (RC-2) is a monocyte-macrophage type, originally isolated by 5 months continuous culture in the presence of colony stimulating factor (CSF). Subsequently, after further culture, this line has become autonomous (RC-2A), no longer requiring CSF for maintenance of proliferation, whilst retaining the characteristics of the original line.
Related Publications
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
April 1986,
Immunology letters,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
March 1987,
Scandinavian journal of immunology,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
January 1980,
Hereditas,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
January 1989,
Journal of cancer research and clinical oncology,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
November 1998,
Science (New York, N.Y.),
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
January 1992,
Cytotechnology,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
February 1992,
Journal of leukocyte biology,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
May 1992,
Journal of neurosurgery,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
July 1975,
British journal of haematology,
T R Bradley, and
G Pilkington, and
M Garson, and
G S Hodgson, and
N Kraft
November 2006,
Nature,
